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Abstract The objective of the study
was to investigate comorbidity of
migraine in Finnish migraine fami-
lies. One thousand consecutive
participants in the Finnish Migraine
Gene Project reported their medical
illnesses in addition to migraine and
headache. Migraine patients (n=678)
reported significantly more hypoten-
sion (OR 1.43, CI 95% 1.02–2.01),
allergy (OR 1.83, CI 95% 1.34–2.51)
and psychiatric disorders (OR 4.09,
CI 95% 2.11–7.92) compared to their
family members without migraine
(n=322). Subgroup analyses demon-
strated that especially women and the
group fulfilling the criteria for both
migraine with and without aura were
likely to have additional disorders
besides their migraine. Interestingly,
male migraineurs with aura reported
a significant association with stroke
and epilepsy. Familial migraine is
comorbid with hypotension, allergy
and psychiatric disorders. The associ-
ation between migraine with aura and
stroke and epilepsy among men of
the studied families warrants further
study. Clinical, pathophysiological
and genetic implications of these
results are discussed.
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Molecular genetic studies have provided important new
ideas concerning migraine pathophysiology. The first two
discovered migraine genes, CACNA1A and ATP1A2 [1, 2],
are genes for the rare migraine subtype, familial hemi-
plegic migraine (FHM). CACNA1A codes for a voltage-
dependent, P/Q-type, alpha-1A subunit calcium channel
and ATP1A2 for a Na+, K+-ATPase alpha-2 subunit. These
findings lead to the hypothesis that migraine could be a
channelopathy, something that resides in the neuronal
membrane, making it more excitable [3, 4]. Similar break-
throughs are awaited for the more common migraine
forms, migraine with and without aura. These disorders
are likely heterogenous and harder to tackle. It seems that
new angles on the migraine phenotype could facilitate the
discovery of a predisposing gene variant. One aspect that
might give additional information on the migraine pheno-
type and might also be helpful in locating new suscepti-
bility genes is migraine comorbidity [5]. This idea is
based on the hypothesis that if two diseases share common
metabolic pathways and part of their pathophysiology it
would be easier to locate the genes by combining infor-
mation concerning the two disorders. Comorbidity of
migraine has been extensively studied and comprehensive
reviews have been published. An association has been
reported with allergies, mitral valve prolapse, hypoten-
sion, hypertension, stroke, depression and anxiety [5].
Based on all the current data, Breslau and Rasmussen [6]
underlined the co-occurrence with psychiatric conditions,
epilepsy and stroke.
In Finland a large family study, the Finnish Migraine
Gene Project, is ongoing [7, 8]. Large Finnish families are
studied clinically and analysed with current molecular
genetic methods in search for genes predisposing to com-
mon forms of migraine, especially migraine with aura.
The objective of the present study is to analyse comorbid-
ity of migraine in the Finnish migraine families and to dis-
cuss how familial comorbidities could help in the genetic
studies. The chosen clinical setting, large migraine fami-
lies, and the scope of the study, 1000 migraineurs, give
unusual importance to the presented observations.
Subjects and methods
Study design
Consecutively identified families with at least three first-degree
family members affected with migraine were recruited nation-
wide for the Finnish Migraine Gene Project [7]. The families
were identified from among patients attending outpatient
headache clinics in six Finnish cities (Helsinki, Kemi, Turku,
Jyväskylä, Mikkeli and Seinäjoki). Nine neurologists (MK, MF,
MN, HH, ES, MI, JL, HT and HH) were in charge of the recruit-
ment. Once a member of the family, the index case, was clini-
cally diagnosed by a neurologist as suffering from migraine, the
index case was asked to contact all other members of the family
believed to suffer from migraine and ask if they would be will-
ing to participate in the study. If at least three possible migraine
sufferers were willing to participate, a validated questionnaire,
the Finnish Migraine Specific Questionnaire for Family Studies
(FMSQFS), was mailed to each of them, their parents and sib-
lings [8]. The FMSQFS has been shown to be both specific and
sensitive in diagnosing migraine in a family setting and also in
differentiating migraine with aura (MwA) from migraine with-
out aura (MwoA) [8].
All participants gave their informed consent to take part in
the study, which was approved by the local ethics committee in
Helsinki.
From among the first 1000 participants, belonging to 251
families, comorbidity of migraine was studied by observing
medical illnesses reported by the participants in the FMSQFS.
Table 1 presents the wording (translated into English) concern-
ing these illnesses in the questionnaire. Migraine cases were
compared to family members without migraine. Differences
between migraine subgroups were noted as well. The FMSQFS
divides participants in the following diagnostic categories:
migraine aura without headache (i.e., migraine equivalents,
Eqv), migraine with aura (MwA), migraine with and without
aura (MwA+MwoA), migraine with aura not fulfilling the cur-
rent criteria (Unc.mig), migraine without aura (MwoA),
headache other than migraine (HA) and no headache (NO). All
these categories are based on the current criteria of the
International Headache Society [9]. The Unc.mig group refers to
patients who have migraine headache according to the criteria
with atypical aura symptoms that do not fulfil the criteria. All
comorbidities reported by the patients were noted and the fol-
lowing were chosen for detailed inspection: epilepsy, stroke,
hypertension, hypotension, allergy and psychiatric disorders.
Statistics
The data were recorded and analysed with a Statview 5.0 soft-
ware package (Abacus Concepts, Inc., Berkley, CA, USA,
1996). Comorbidities in various study groups were analysed
with multiple logistic regression. For age adjustment partici-
pants were divided into age groups <25, between 25 and 50, and
>50 years of age, after which CIA Software (Trevor N. Bryant,
2000) was used to calculate age-adjusted standardised rates for
different comorbidities. Multiple logistic regression odds ratios
(OR) adjusted for age are shown with 95% confidence intervals.
Results
The 1000 participants belonged to 251 separate families;
606 were women, 394 men. The mean age was 40.0 years
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(SD±18.8 years), 40.8 years (SD±18.6 years) for women
and 38.8 years (SD±19.1 years) for men. Five partici-
pants, three women and two men, did not report their
ages. A total of 678 were diagnosed as having migraine;
478 of these migraineurs were women and 200 men.
Sixteen patients were diagnosed as Eqv, 226 individuals
as MwA+MwoA, 140 individuals as MwA, 144 migraine
with Unc.mig and 152 as MwoA. Mean age of the
migraine patients was 38.5 years (SD±17.6 years), 39.6
(SD±17.3 years) for women and 36.0 (SD±18.1 years) for
men. Mean age of the family members not affected by
migraine was 43.1 (SD±20.8 years), 45.4 (SD±22.3
years) for women and 41.6 (SD±19.7 years) for men.
Two participants did not report their medical illnesses
and 43 did not report their blood pressure.
Distribution of comorbidities (Table 2) differed
between participants with and without migraine. Migraine
patients reported statistically significantly more hypoten-
sion (OR 1.43, CI 95% 1.02–2.01), allergy (OR 1.83, CI
95% 1.34–2.51) and psychiatric disorders (OR 4.09, CI
95% 2.11–7.92) compared with their family members
without migraine. Differences regarding epilepsy, stroke
and hypertension were not statistically significant. Table 2
also shows results divided by gender.
There were 8 strokes among 304 women younger than
45 years with migraine (2.6%). Compared to the corre-
Table 1 Wording used in the FMSQFS concerning illnesses of participants
Previous illnesses:
Do you have or have you had:
- Stroke (or cerebral infarction) (  )
- Intracerebral haemorrhage (  )
- Other cerebral circulatory disorder of what kind:.......................................................................................................................................................... (  )
- Epilepsy (  )
- Seizure (  )
- Fit of unconsciousness (  )
- Fever convulsion as a child (  )
- Hypertension (  )
- Myocardial infarction (  )
- Symptomatic heart disease (  )
- Cardiac insufficiency (  )
- Atrial fibrillation (  )
- Other cardiac arrhythmia (  )
- Ménière’s disease (  )
- Eye disease 
which: ................................................................................................................................................................................................................................................ (  )
- Diabetes 
which: ................................................................................................................................................................................................................................................ (  )
- Cancer
which: ................................................................................................................................................................................................................................................ (  )
- Rheumatic condition 
which: ................................................................................................................................................................................................................................................ (  )
- Allergy or atopy:
which one:........................................................................................................................................................................................................................................ (  )
- Mental disorder (  )
Depression, severe depression (  )
Anxiety disorder that needed treatment (  )
Panic disorder (  )
Insomnia (  )
Other, which: .................................................................................................................................................................................................................................. (  )
- High cholesterol level (  )
- High triglyceride level (  )
- Do you have or have you had some other significant illness: (  )
which: ................................................................................................................................................................................................................................................
None of the above (  )
- Your latest blood pressure value was ............................................................... / ................................................................ mmHg (systolic/diastolic)
- You do not remember but you were told it was or has been: (  )
High (   ) Low (   ) Normal (   ) Yes (  ) No (  )
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sponding figure in non-migraineurs (1 stroke in 57 partic-
ipants, 1.7%), the difference is not statistically significant.
Some gender differences were observed between
migraineurs (Table 3). Women with migraine had signif-
icantly more hypotension (OR 4.40, CI 95% 2.65–7.32),
allergy (OR 1.91, CI 95% 1.31–2.78) and psychiatric
disorders (OR 2.67, CI 95% 1.34–5.34) than men with
migraine.
Table 4 presents reported comorbidities in the differ-
ent diagnostic categories of the study. The MwA,
MwA+MwoA and Unc.mig groups reported significantly
more allergy and psychiatric disorders compared to the
NO category (MwA OR 1.68 (CI 95% 1.01–2.79) for
allergy and OR 3.46 (CI 95% 1.17–10.21) for psychiatric
disorders, MwA+MwoA OR 1.86 (CI 95% 1.17–2.97)
for allergy and OR 5.91 (CI 95% 2.16–16.20) for psy-
chiatric disorders and Unc.mig OR 1.68 (CI 95%
1.02–2.78) for allergy and OR 5.21 (CI 95% 1.80–15.05)
for psychiatric disorders.
Additionally, subgroup analysis showed that women
with MwA+MwoA reported more hypotension (OR 2.12,
CI 95% 1.065–4.23) and men with MwA+MwoA reported
more epilepsy (OR 6.76, CI 95% 1.028–44.48) and stroke
(OR 15.19, CI 95% 1.15–200.88) than the NO group.
Epilepsy was also common among men with Unc.mig (OR
5.88, CI 95% 1.063–32.57) compared to the NO group.
There was no significant difference between MwoA
and NO groups or between Eqv and NO groups.
Table 2 Comorbidities in family members with migraine compared to family members without migraine
Comorbidity studied Family members Family members OR (95% CI)
with migraine without migraine
(n=676) (n=322)
% %
Epilepsy 4.1 2.9 1.38 (0.64–2.97)
Women 3.1 3.4 0.76 (0.27–2.15)
Men 6.1 2.4 2.84 (0.89–9.04)
Stroke 2.5 1.6 1.74 (0.66–4.60)
Women 2.5 2.2 1.36 (0.37–5.10)
Men 2.5 1.3 2.39 (0.48–11.73)
Hypertension 11.8 11.6 1.11 (0.71–1.73)
Women 11.5 11.3 1.25 (0.65–2.39)
Men 12.1 11.5 1.12 (0.57–2.18)
Hypotension 26.0 20.7 1.43 (1.02–2.01)
Women 32.1 30.8 1.32 (0.83–2.09)
Men 10.7 16.3 0.64 (0.32–1.14)
Allergy 34.0 22.0 1.83 (1.34–2.51)
Women 37.4 22.0 2.01 (1.26–3.19)
Men 25.4 22.2 1.18 (0.73–1.92)
Psychiatric disorder 11.1 2.9 4.09 (2.11–7.92)
Women 12.9 5.6 2.82 (1.28–6.19)
Men 5.1 1.3 3.90 (1.03–14.67)
Results are controlled for age
CI, confidence interval; OR, odds ratio
Table 3 Comorbidities in women with migraine compared to men with migraine
Comorbidity studied Women with migraine, % Men with migraine, % OR (95% CI)
Epilepsy 3.1 6.1 0.50 (0.23–1.07)
Stroke 2.5 2.5 1.1 (0.35–3.51)
Hypertension 11.5 12.1 0.85 (0.48–1.53)
Hypotension 32.1 10.7 4.40 (2.65–7.32)
Allergy 37.4 25.4 1.91 (1.31–2.78)
Psychiatric disorder 12.9 5.1 2.67 (1.34–5.34)
Results are controlled for age




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Results of this Finnish family study confirm many previ-
ous reports concerning comorbidity of migraine [5, 6, 10].
In the study population allergy and psychiatric condi-
tions were comorbid with migraine, as reported previous-
ly [11–13]. In a more detailed analysis the disorders were
especially prevalent among the MwA+MwoA, Unc.mig
and MwA phenotypes. Thus allergy and psychiatric con-
ditions could have more links to the aura phase of
migraine. This association is clearly more pronounced
among women.
A strong association of migraine and epilepsy has been
shown in a previous family study by Ottman and Lipton
[10]. In our families epilepsy was significantly associated
with migraine only among men. Again it seems that asso-
ciation is somehow linked to the aura phase because sta-
tistical significance was found only in Mwa+MwoA and
Unc.mig groups. Thus it seems that the common back-
ground underlying migraine and epilepsy exists also in
these families, but the association is only minor, and pos-
sibly greater among men. It is clear that caution is war-
ranted concerning the observation, because of the small
number of epilepsy cases (17) among participating men.
Overall it can be stated again that further studies, also
genetic, are needed to elucidate the interesting links
between migraine and epilepsy.
The well known association of migraine and stroke
[14] was not striking. In the rare cases when stroke was
present, it seemed to occur more often in patients with
aura, as has been reported before [14]. The only signifi-
cant finding in this regard was that men who fulfilled the
criteria of both migraine with and without aura had a
15.19 times higher risk for stroke than men without
migraine. Here again the small number of strokes has to
be noted. Probably there are multiple, acquired and genet-
ic, factors that occasionally cause a migraine patient to
have a stroke. The familial liability to migraine seems to
be a rather small contributor.
We found an association between hypotension and
migraine among the female participants. The risk for
hypotension was 4.4 times higher among women with
migraine than men with migraine. Especially the
MwA+MwoA phenotype stands out. The relationship
between blood pressure and migraine is controversial.
Most of the studies that show an association between
hypertension and migraine were done before the intro-
duction of the International Headache Society (IHS) cri-
teria in 1988. Recently Wiehe et al. [15] and Lee et al.
[16] reported an association between low blood pressure
and migraine. Again further and more detailed studies
into this association will be very interesting. It seems
that gender and migraine subgroup related differences
are important. All significant findings were from sub-
groups of patients who have aura (MwA, MwA+MwoA,
Unc.mig).
Some reservations are appropriate when analysing the
presented data. The applied questionnaire, the FMSQFS,
has been validated for migraine, not for the comorbid dis-
eases. Table 1 presents the wording (translated into
English) concerning associated diseases in the question-
naire. Thus, precise incidence or prevalence figures can-
not be drawn from the data. This might be especially
notable concerning specific psychiatric disorders. The
focus should be on the reported differences between those
with and those without migraine. This is of course a limi-
tation, but as the FMSQFS is already extensive, more pre-
cise questioning would probably have resulted in exhaus-
tion of the participants. Overall, it can be said that the pre-
sented observations are very much in line with previous
literature, which further supports the reliability of the
methods used in the present study.
There are several implications of the data when
migraine pathophysiology and treatment are considered.
Prophylaxis of stroke and hypertension are important
also in familial migraine, but overemphasis is not war-
ranted. Treatment of allergic conditions is important, and
could also relieve migraine. Psychiatric conditions,
especially depression, are essential, and their treatment
should be part of comprehensive migraine care.
Antiepileptic medications could be especially good
choices for migraine prophylaxis if there is a family his-
tory of comorbid epilepsy, especially among men, and if
there is a tendency towards low blood pressure in the
family, other prophylaxis besides beta-blockers seems
appropriate. From a pathophysiological point of view,
studies involving ion channels (epilepsy), mechanisms
related to the ANS (hypotension), immunology (allergy)
and serotonergic transmission (psychiatric conditions)
are indicated.
The presented data show that family data can be effec-
tively used to study comorbidity of migraine. Besides
therapeutical implications, this can be important when the
elusive genes for the common forms of migraine,
migraine with and without aura, are searched for.
Migraine families can be sorted out based on their famil-
ial comorbidities (epilepsy, stroke, hypertension, hypoten-
sion, allergy, psychiatric conditions) and the groups stud-
ied separately. This, most probably, could lead to more
homogenous study populations and, at the same time, the
likelihood that the current molecular genetic methods can
locate new migraine genes is increased.
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